Systemic immune-inflammation index as a predictor of statin residual cardiovascular risk compared with C-reactive protein

Among patients receiving contemporary statins, SII was shown to be an independent predictor of future CV death. SII outperformed CRP as an inflammatory biomarker for residual CV risk in statin-treated patients.